a 3697 bp plasmidderived from pVAX1LacZ (Invitrogen, Carlsbad, CA), containing thehuman cytomegalovirus (CMV) immediate-early promoter, a ColE1type origin of replication and the kanamycin resistance gene forbacterial selection, as described previously